A Comparison of Three Interferon Alfa-2b Regimens for the Long-TermTreatment of Chronic Non-A, Non-B Hepatitis . On page 1461,the numbers in the legend for Figure 1 were calculated incorrectly.The corrected legend appears below.
Among the patients with normal serum alanine aminotransferaseconcentrations at six months, histologic improvement was observedin 78.6 percent of the patients in group 1 (22 of 28), 68.0percent of those in group 2 (17 of 25), and 55.0 percent ofthose in group 3 (11 of 20). Among the patients with elevatedserum alanine aminotransferase concentrations at six months,histologic improvement was observed in 60.7 percent of the patientsin group 1 (17 of 28), 34.2 percent of those in group 2 (13of 38), and 29.7 percent of those in group 3 (11 of 37). Amongthe patients with normal serum alanine aminotransferase concentrationsat 18 months, histologic improvement was observed in 83.9 percentof the patients in group 1 (26 of 31), 72.2 percent of thosein group 2 (13 of 18), and 57.9 percent of those in group 3(11 of 19). Among the patients with elevated serum alanine aminotransferaseconcentrations at 18 months, histologic improvement was observedin 52.0 percent of those in group 1 (13 of 25), 37.8 percentof those in group 2 (17 of 45), and 28.9 percent of those ingroup 3 (11 of 38).
Correction
to
Poynard et al., 
Previous
